SIM
LABU icon

Seaview Investment Managers’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Seaview Investment Managers’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,500
Closed -$213K – 142
2025
Q1 		$213K Buy
+3,500
New +$298K 0.05% 112
2023
Q1 		– Sell
-705
Closed -$99.7K – 107
2022
Q4 		$99.7K Buy
+705
New +$98.3K 0.04% 85

Other funds holding LABU

TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EFG
Ethos Financial Group King Of Prussia, Pennsylvania $1.37B AUM 19.43% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Seaview Investment Managers's LABU Position: Q2 2025 in Review

Seaview Investment Managers sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2025, closing a stake of 3,500 shares — an estimated $213K sold.

Seaview Investment Managers first reported a position in LABU in Q4 2022 and held it in 2 quarters. The position peaked at $213K in Q1 2025. 33 funds tracked by Wall St. Rank hold LABU as of Q2 2025.

  • Seaview Investment Managers reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q2 2025 after selling out during the quarter.
  • Seaview Investment Managers sold 3,500 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2025, an estimated $213K.
  • Seaview Investment Managers first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2022 and held it in 2 quarters.
  • Seaview Investment Managers's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $213K in Q1 2025.
  • 33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2025.

Based on Seaview Investment Managers's 13F filing for Q2 2025, filed 12 Aug 2025.